Rituximab Therapeutic Cheat Sheet
RituximabRituximab was the first monoclonal antibody approved for cancer treatment and now in dermatology, this medication has been life-altering for patients with the severe, autoimmune blistering disease, pemphigus vulgaris. We continue our series, Therapeutic Cheat Sheet, with a closer look at rituximab, which is FDA-approved for the treatment of pemphigus vulgaris, and is also used off label for other …
Rituximab
Leukemia Cutis in Skin of Color
leukemia cutisThe various presentations of many dermatologic conditions among various skin types are slowly being elucidated throughout the recent years. These differences present as an issue as it leads to delayed diagnosis, treatment, and poorer quality of life. Herein, JDD authors  Susuana Adjei MD, et al.  present the characteristics of leukemia cutis in a skin of color patient with diagnosed chronic myel …
leukemia cutis
Friday Pop Quiz #222
The correct answer is D. Silica. The image shows a foreign body reaction with sarcoidal granulomas consistent with such a reaction. The presence of colorless, birifrigent crystals is most characteristic of silicosis. Aluminum and zirconium have no polarizable crystals, while sarcoidosis and gout have different presentations from a foreign body reaction. References Pimentel L, Barna …
Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several …
JDD May 2023 Issue Highlights | Special Focus: Skin Cancer
skin cancerThe May issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and includes the perfect blend of original articles and case reports. Topics include actinic keratosis versus squamous cell carcinoma, the utility of gene expression profiling in skin cancer, the prevalence of sunscreen use, and many more.  Check out this month’s issue highlights straight from the JDD Editor’s …
skin cancer
error

Enjoy this blog? Please spread the word :)